0000000000338628
AUTHOR
S. Bauer
showing 12 related works from this author
Commissioning of the vacuum system of the KATRIN Main Spectrometer
2016
The KATRIN experiment will probe the neutrino mass by measuring the β-electron energy spectrum near the endpoint of tritium β-decay. An integral energy analysis will be performed by an electro-static spectrometer (``Main Spectrometer''), an ultra-high vacuum vessel with a length of 23.2 m, a volume of 1240 m[superscript 3], and a complex inner electrode system with about 120 000 individual parts. The strong magnetic field that guides the β-electrons is provided by super-conducting solenoids at both ends of the spectrometer. Its influence on turbo-molecular pumps and vacuum gauges had to be considered. A system consisting of 6 turbo-molecular pumps and 3 km of non-evaporable getter strips ha…
15. Mainzer Allergie-Workshop 2003
2003
Reduction of stored-particle background by a magnetic pulse method at the KATRIN experiment
2018
Arenz, M., et al. “Reduction of Stored-Particle Background by a Magnetic Pulse Method at the KATRIN Experiment.” The European Physical Journal C, vol. 78, no. 9, Sept. 2018. © 2018 The Authors
Experimental evidence for a motivational origin of cognitive impairment in major depression.
2007
BackgroundDiagnostic criteria and empirical evidence support the existence of cognitive deficits in depression. However, depressed mood, loss of interest and low self-efficacy might influence cognitive performance.MethodGoal-setting instructions were used to promote motivation in depressed patients and control subjects during neuropsychological assessment. The resulting performance was compared with performance using standard instructions. Sixty in-patients with non-psychotic unipolar depression and 60 age- and education-matched healthy control subjects were assessed with standard neuropsychological tests [the Auditory Verbal Learning Test (AVLT), the Digit Symbol Test (DST), the Regensburg…
High-voltage monitoring with a solenoid retarding spectrometer at the KATRIN experiment
2014
The KATRIN experiment will measure the absolute mass scale of neutrinos with a sensitivity of m(ν) = 200meV/c(2) by means of an electrostatic spectrometer set close to the tritium β-decay endpoint at 18.6keV. Fluctuations of the energy scale must be under control within ±60mV (±3ppm). Since a precise voltage measurement in the range of tens of kV is on the edge of current technology, a nuclear standard will be deployed additionally. Parallel to the main spectrometer the same retarding potential will be applied to the monitor spectrometer to measure 17.8-keV K-conversion electrons of (83m)Kr. This article describes the setup of the monitor spectrometer and presents its first measurement resu…
Improved Upper Limit on the Neutrino Mass from a Direct Kinematic Method by KATRIN
2019
We report on the neutrino mass measurement result from the first four-week science run of the Karlsruhe Tritium Neutrino experiment KATRIN in spring 2019. Beta-decay electrons from a high-purity gaseous molecular tritium source are energy analyzed by a high-resolution MAC-E filter. A fit of the integrated electron spectrum over a narrow interval around the kinematic end point at 18.57 keV gives an effective neutrino mass square value of (−1.0−1.1+0.9) eV2. From this, we derive an upper limit of 1.1 eV (90% confidence level) on the absolute mass scale of neutrinos. This value coincides with the KATRIN sensitivity. It improves upon previous mass limits from kinematic measurements by almost a …
An angular-selective electron source for the KATRIN experiment
2014
The KATRIN experiment is going to search for the average mass of the electron antineutrino with a sensitivity of 0.2 eV/c2. It uses a retardation spectrometer of MAC-E filter type to accurately measure the shape of the electron spectrum at the endpoint of tritium beta decay. In order to achieve the planned sensitivity the transmission properties of the spectrometer have to be understood with high precision for all initial conditions. For this purpose an electron source has been developed that emits single electrons at adjustable total energy and adjustable emission angle. The emission is pointlike and can be moved across the full flux tube that is imaged onto the detector. Here, we demonstr…
Ultra-stable implanted 83Rb/83mKr electron sources for the energy scale monitoring in the KATRIN experiment
2012
The KATRIN experiment aims at the direct model-independent determination of the average electron neutrino mass via the measurement of the endpoint region of the tritium beta decay spectrum. The electron spectrometer of the MAC-E filter type is used, requiring very high stability of the electric filtering potential. This work proves the feasibility of implanted 83Rb/83mKr calibration electron sources which will be utilised in the additional monitor spectrometer sharing the high voltage with the main spectrometer of KATRIN. The source employs conversion electrons of 83mKr which is continuously generated by 83Rb. The K-32 conversion line (kinetic energy of 17.8 keV, natural line width of 2.7 e…
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, mu…
2013
Contains fulltext : 118365.pdf (Publisher’s version ) (Closed access) BACKGROUND: Until now, only imatinib and sunitinib have proven clinical benefit in patients with gastrointestinal stromal tumours (GIST), but almost all metastatic GIST eventually develop resistance to these agents, resulting in fatal disease progression. We aimed to assess efficacy and safety of regorafenib in patients with metastatic or unresectable GIST progressing after failure of at least imatinib and sunitinib. METHODS: We did this phase 3 trial at 57 hospitals in 17 countries. Patients with histologically confirmed, metastatic or unresectable GIST, with failure of at least previous imatinib and sunitinib were rando…
First-in-human study of IMAB362, an anti-claudin 18.2 monoclonal antibody, in patients with advanced gastroesophageal cancer
2017
Efficacy and Safety of Multiple Doses of Imab362 in Patients with Advanced Gastro-Esophageal Cancer: Results of a Phase Ii Study
2014
ABSTRACT Aim: IMAB362 is a monoclonal antibody specifically targeting claudin 18 isoform 2 (CLDN18.2), which is expressed on gastric cancer cells, whereas it is only present on a fraction of healthy stomach cells. This may reduce the risk of target-related side effects. Single-agent IMAB362 appears safe in patients with advanced gastro-esophageal cancer (GEC) based on data from a phase I trial. Methods: This international, multicenter, non-randomized phase IIa study (NCT01197885) investigated the efficacy and safety of repeated doses of IMAB362 (300 and 600 mg/m2) in patients with metastatic, refractory/recurrent, CLDN18.2-positive GEC (i.e. cancer of the stomach, the lower esophagus and th…